Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as suppression of 5-HT levels in serum at 10 mg/kg, ip dosed daily for 1 week by LC-MS/MS analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as suppression of 5-HT levels in brain at 10 mg/kg, ip dosed daily for 1 week by LC-MS/MS analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as suppression of 5-HT levels in serum at 10 mg/kg, ip dosed daily for 8 weeks by LC-MS/MS analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as suppression of body weight gain at 10 mg/kg, ip dosed daily for 8 weeks by LC-MS/MS analysis
Anti-obesity activity in overnight fasted C57BL/6J mouse model of diet-induced obesity assessed as improvement in glucose tolerance at 1 to 10 mg/kg, ip by intraperitoneal glucose tolerance test
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipose tissues by measuring eWAT at 10 mg/kg, ip dosed daily for 8 weeks
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipose tissues by measuring iWAT at 10 mg/kg, ip dosed daily for 8 weeks
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipose tissues by measuring BAT at 10 mg/kg, ip dosed daily for 8 weeks
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipose tissue inflammation at 10 mg/kg, ip dosed daily for 8 weeks by H and E staining based histological analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipocyte size in eWAT at 10 mg/kg, ip dosed daily for 8 weeks by H and E staining based histological analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in adipocyte size in iWAT at 10 mg/kg, ip dosed daily for 8 weeks by H and E staining based histological analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as reduction in lipid droplet size at 10 mg/kg, ip dosed daily for 8 weeks by H and E staining based histological analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as increase in multilocular adipocytes at 10 mg/kg, ip dosed daily for 8 weeks by H and E staining based histological analysis
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as increase in VO2 at 10 mg/kg, ip dosed daily for 8 weeks by indirect calorimetry
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as increase in VCO2 at 10 mg/kg, ip dosed daily for 8 weeks by indirect calorimetry
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as increase in heat production at 10 mg/kg, ip dosed daily for 8 weeks by indirect calorimetry
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as effect on RER at 10 mg/kg, ip dosed daily for 8 weeks by indirect calorimetry
Anti-obesity activity in C57BL/6J mouse model of diet-induced obesity assessed as induction of thermogenic activity by measuring increase in Ucp1 mRNA expression in BAT at 10 mg/kg, ip dosed daily for 8 weeks by RT-PCR analysis